These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8641298)

  • 21. Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults.
    Hendriksz T; Malouf P; Foy JE;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S10-2. PubMed ID: 22086887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradermal zoster vaccines: good for the old and the young.
    Br Dent J; 2016 Nov; 221(10):632. PubMed ID: 27857091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella and herpes zoster vaccines: WHO position paper, June 2014--Recommendations.
    Vaccine; 2016 Jan; 34(2):198-199. PubMed ID: 26723191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated varicella vaccine.
    Gershon AA
    J Infect Dis; 1985 Nov; 152(5):859-62. PubMed ID: 2995509
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
    Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
    Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox.
    Gershon AA; LaRussa P; Steinberg S; Mervish N; Lo SH; Meier P
    J Infect Dis; 1996 Feb; 173(2):450-3. PubMed ID: 8568309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella and herpes zoster vaccines: WHO position paper, June 2014.
    Wkly Epidemiol Rec; 2014 Jun; 89(25):265-87. PubMed ID: 24983077
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective versus universal vaccination for varicella zoster virus infection: what holds the key to successful disease control?
    Schleiss M
    Herpes; 2005 Oct; 12(2):32. PubMed ID: 16209857
    [No Abstract]   [Full Text] [Related]  

  • 31. [Viral vaccines in the national vaccination program--views of the near future].
    Vesikari T
    Duodecim; 2013; 129(22):2427-33. PubMed ID: 24397154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella-zoster vaccination for health care workers.
    Simini B
    Lancet; 1994 May; 343(8909):1363. PubMed ID: 7910352
    [No Abstract]   [Full Text] [Related]  

  • 33. Trends in rates of herpes zoster-related hospitalizations: are they real, are they costly, and are they linked to varicella vaccination?
    Harpaz R; Yawn BP
    Infect Control Hosp Epidemiol; 2009 May; 30(5):495-6; author reply 496-7. PubMed ID: 19344268
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Varicella-zoster virus vaccine].
    Asano Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():619-24. PubMed ID: 15954419
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA approves shingles vaccine: herpes zoster vaccine targets older adults.
    Mitka M
    JAMA; 2006 Jul; 296(2):157-8. PubMed ID: 16835412
    [No Abstract]   [Full Text] [Related]  

  • 37. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccine against varicella-zoster].
    Nicodemo AC; Nicodemo EL; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):55-8. PubMed ID: 2831610
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.